21 – 30 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
(
- Contribution to journal › Article
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
-
Mark
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension : A Swedish single-center study
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
(
- Contribution to journal › Letter
-
Mark
Plasma VEGF-D and sFLT-1 are potential biomarkers of hemodynamics and congestion in heart failure and following heart transplantation
(
- Contribution to journal › Article
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
(
- Contribution to journal › Letter
- 2022
-
Mark
Bone mineral density in pediatric heart transplanted patients: A retrospective single-centre study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article